Cite
Kepp O, Menger L, Vacchelli E, et al. Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effects. Oncoimmunology. 2012;1(9):1640-1642doi: 10.4161/onci.21684.
Kepp, O., Menger, L., Vacchelli, E., Adjemian, S., Martins, I., Ma, Y., Sukkurwala, A. Q., Michaud, M., Galluzzi, L., Zitvogel, L., & Kroemer, G. (2012). Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effects. Oncoimmunology, 1(9), 1640-1642. https://doi.org/10.4161/onci.21684
Kepp, Oliver, et al. "Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effects." Oncoimmunology vol. 1,9 (2012): 1640-1642. doi: https://doi.org/10.4161/onci.21684
Kepp O, Menger L, Vacchelli E, Adjemian S, Martins I, Ma Y, Sukkurwala AQ, Michaud M, Galluzzi L, Zitvogel L, Kroemer G. Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effects. Oncoimmunology. 2012 Dec 01;1(9):1640-1642. doi: 10.4161/onci.21684. PMID: 23264921; PMCID: PMC3525630.
Copy
Download .nbib